AstraZeneca’s senior director in oncology data science outlined how the company uses AI for drug discovery at a recent talk.
AstraZeneca has advanced its push to make camizestrant a blockbuster, reporting a phase 3 win for the oral SERD at an interim analysis. The trial hit on progression-free survival (PFS), its ...
Drugmaker AstraZeneca has teamed up with Indian digital ... The aim of the pilot is to scan and review more than 250,000 images generated at clinics in the Greater Manchester Cancer Alliance ...